Use of low-molecular-weight heparin to decrease mortality in mice after intracardiac injection of tumor cells.
about
Identification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasisBioequivalence study of two subcutaneous formulations of dalteparin: randomized, single-dose, two-sequence, two-period, cross-over study in healthy volunteers.
P2860
Use of low-molecular-weight heparin to decrease mortality in mice after intracardiac injection of tumor cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Use of low-molecular-weight he ...... diac injection of tumor cells.
@en
Use of low-molecular-weight he ...... diac injection of tumor cells.
@nl
type
label
Use of low-molecular-weight he ...... diac injection of tumor cells.
@en
Use of low-molecular-weight he ...... diac injection of tumor cells.
@nl
prefLabel
Use of low-molecular-weight he ...... diac injection of tumor cells.
@en
Use of low-molecular-weight he ...... diac injection of tumor cells.
@nl
P2093
P2860
P1433
P1476
Use of low-molecular-weight he ...... rdiac injection of tumor cells
@en
P2093
Bernard S Buetow
Jon C Jones
Kim L Stocking
Martine P Roudier
Nancy E Everds
Robert E Miller
P2860
P577
2009-02-01T00:00:00Z